C-T Yeh
Overview
Explore the profile of C-T Yeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
366
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lai M, Liang K, Yeh C
Clin Microbiol Infect
. 2019 Feb;
25(9):1140-1146.
PMID: 30771531
Objectives: We aimed to investigate immunity against hepatitis B surface antigen (HBsAg) mutants before and after boosters in adolescents who had lost antibodies against HBsAg (anti-HBs) despite neonatal vaccination. Methods:...
2.
Hsu F, Chiang M, Li F, Yeh C, Lee W, Chau L
Oncogene
. 2017 Aug;
36(49):6805-6814.
PMID: 28846111
Overexpression of heme oxygenase-1 (HO-1), an endoplasmic reticulum-anchored enzyme, is observed in many cancers. HO-1 nuclear translocation has been shown to correlate with progression of several cancers. We recently reported...
3.
Chi H, Chen S, Lin S, Tsai C, Chuang W, Lin Y, et al.
Oncogene
. 2017 May;
36(37):5274-5284.
PMID: 28504722
Infection by hepatitis B virus (HBV) accounts for 50-80% of hepatocellular carcinoma (HCC) development worldwide, in which the HBV-encoded X protein (HBx) has critical role in the induction of carcinogenesis....
4.
Lai M, Liang K, Lin W, Huang Y, Huang S, Chen T, et al.
Oncogenesis
. 2016 Dec;
5(12):e273.
PMID: 27918551
Hepatitis B virus (HBV) carrying the rtA181T/sW172* mutation conferred cross-resistance to adefovir and lamivudine. Cell-based and clinical studies indicated that HBV carrying this mutation had an increased oncogenic potential. Herein,...
5.
Kuo K, Chen C, Chou T, Yeh C, Lee W, Wang L
Oncogenesis
. 2016 Jul;
5(7):e239.
PMID: 27376780
Esophageal cancer is a lethal malignancy worldwide. Previously, low expression of metastasis suppressor Nm23H1 and tight junction (TJ) protein claudin-1 (CLDN1) have been known to correlate with poor prognosis in...
6.
Chang M, Huang Y, Cheng J, Yeh C
J Viral Hepat
. 2015 Nov;
23(4):256-66.
PMID: 26537061
Membrane type 1 matrix metalloproteinase (MT1-MMP) binds to and regulates the function of tetraspanin-enriched microdomains. It also physically interacts with claudin-1 and acireductone dioxygenase 1 (ADI1), both associated with hepatitis...
7.
Cheng H, Liang Y, Kuo Y, Chuu C, Lin C, Lee M, et al.
Cell Death Dis
. 2015 May;
6:e1753.
PMID: 25950483
Glioblastoma (GBM) is a common and malignant tumor with a poor prognosis. Glioblastoma stem cells (GSCs) have been reported to be involved in tumorigenesis, tumor maintenance and therapeutic resistance. Thus,...
8.
Hsu F, Yeh C, Sun Y, Chiang M, Lan W, Li F, et al.
Oncogene
. 2015 May;
34(18):2410-1.
PMID: 25924715
No abstract available.
9.
Guo W, Liu R, Bhardwaj G, Yang J, Changou C, Ma A, et al.
Cell Death Dis
. 2014 Sep;
5:e1409.
PMID: 25188519
Btk and Etk/BMX are Tec-family non-receptor tyrosine kinases. Btk has previously been reported to be expressed primarily in B cells and has an important role in immune responses and B-cell...
10.
Hsu F, Yeh C, Sun Y, Chiang M, Lan W, Li F, et al.
Oncogene
. 2014 Jun;
34(18):2360-70.
PMID: 24931165
Heme oxygenase-1 (HO-1) is a heme-degrading enzyme anchored in the endoplasmic reticulum by a carboxyl-terminal transmembrane segment (TMS). HO-1 is highly expressed in various cancers and its nuclear localization is...